Natural Alternatives International (NAII) vs Regencell Bioscience (RGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Regencell Bioscience is the larger company by market cap ($3.64 billion vs $7.1 million), about 510.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAII | RGC |
|---|---|---|
| Share price | $1.14 | $7.35 |
| Market cap | $7.14M | $3.64B |
| 1-day change | -0.44% | -3.67% |
| YTD return | — | -65.00% |
| 1-year return | — | -60.14% |
| 5-year return | — | +1398.47% |
| EPS (TTM) | $-3.37 | $-0.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-11.70M |
| 52-week high | $4.96 | $69.00 |
| 52-week low | $1.11 | $4.51 |
| Distance from 52-week high | -77.02% | -89.35% |
| Average volume | 39.69K | 196.76K |
| Shares outstanding | 6.26M | 495.88M |
| Employees | 301 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Regencell Bioscience is about 510.3 times larger than Natural Alternatives International by market value ($3.64B vs $7.14M).
About Natural Alternatives International
NAII stock →Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally.
Health Care · Medicinal Chemicals and Botanical Products · 301 employees
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
NAII vs RGC FAQ
Which is bigger, Natural Alternatives International or Regencell Bioscience?
Regencell Bioscience (RGC) is larger, with a market capitalization of $3.64B compared with $7.14M for Natural Alternatives International (NAII).
Are Natural Alternatives International and Regencell Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.